Unresectable stage III non-small-cell lung cancer: state of the art and challenges

Jordi Remon; Antonin Levy; Romane Gille; Isabelle Martel-Lafay; Martina Bortolot; Lizza E. L. Hendriks; Corinne Faivre-Finn; Natasha Leighl; Martin Reck; Maurice Pérol

doi:10.1038/s41571-025-01080-4

Unresectable stage III non-small-cell lung cancer: state of the art and challenges

J Jordi Remon A Antonin Levy R Romane Gille I Isabelle Martel-Lafay M Martina Bortolot L Lizza E. L. Hendriks C Corinne Faivre-Finn N Natasha Leighl M Martin Reck M Maurice Pérol

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Nature Reviews Clinical Oncology

Volume / Issue Vol. 23, Issue 1

Published January 01, 2026

Pages 22-39

DOI 10.1038/s41571-025-01080-4

ISSN 1759-4774

Publisher Springer Science and Business Media LLC

Journal Info

Nature Reviews Clinical Oncology

Springer Science and Business Media LLC

ISSN: 1759-4774 Q1 Medicine

Authors (10)

J

Jordi Remon

A

Antonin Levy

R

Romane Gille

I

Isabelle Martel-Lafay

M

Martina Bortolot

L

Lizza E. L. Hendriks

C

Corinne Faivre-Finn

N

Natasha Leighl

M

Martin Reck

M

Maurice Pérol

Unresectable stage III non-small-cell lung cancer: state of the art and challenges

Article Details

Journal Info

Authors (10)

Related Articles from this Journal

Ibrutinib improves overall survival in patients with mantle cell lymphoma

First-line zanidatamab–chemotherapy with or without tislelizumab improves survival in advanced-stage HER2+ GEA

Clinical implementation of multi-cancer early detection tests: can we find a path forward?

Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancer

Liquid biopsy to inform adjuvant decisions during neoadjuvant chemotherapy — a full-circle moment for nasopharyngeal cancer